— Know what they know.
Not Investment Advice

NEO NASDAQ

NeoGenomics, Inc.
1W: +9.0% 1M: +11.4% 3M: -7.9% YTD: -22.5% 1Y: +14.0% 3Y: -49.1% 5Y: -76.1%
$9.23
+0.12 (+1.32%)
 
Weekly Expected Move ±7.0%
$7 $8 $8 $9 $9
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 61 · $240.4M mcap · 24M float · 8.32% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.7 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -7.2%  ·  5Y Avg: -7.3%
Cost Advantage
52
Intangibles
34
Switching Cost
59
Network Effect
39
Scale
28
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NEO shows a Weak competitive edge (43.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. Negative ROIC of -7.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$25
Low
$25
Avg Target
$25
High
Based on 1 analyst since Apr 28, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 22Hold: 5Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$19.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-29 Leerink Partners $14 $25 +11 +177.2% $9.02
2026-02-24 Piper Sandler $11 $13 +2 +30.4% $9.97
2025-10-28 Leerink Partners Initiated $14 +41.1% $9.92
2025-09-02 Stephens $18 $11 -7 +24.9% $8.81
2025-08-04 Piper Sandler $12 $11 -1 +94.0% $5.67
2025-07-30 Morgan Stanley $18 $8 -10 +56.9% $5.10
2025-07-29 Needham $19 $8 -11 +52.4% $5.25
2025-05-06 Piper Sandler David Westenberg $19 $12 -7 +53.1% $7.84
2025-01-11 BTIG Mark Massaro $21 $18 -3 +21.9% $14.77
2024-07-30 Needham Mike Matson $16 $19 +3 +29.8% $14.64
2024-05-02 BTIG Mark Massaro Initiated $21 +50.4% $13.96
2023-08-21 Stephens Mason Carrico Initiated $18 +27.8% $14.08
2022-08-17 Piper Sandler David Westenberg Initiated $19 +63.2% $11.64
2022-08-10 Morgan Stanley Initiated $18 +54.4% $11.66
2022-08-10 Goldman Sachs $55 $20 -35 +72.6% $11.59
2022-08-10 Needham Initiated $16 +37.0% $11.68
2022-04-28 Raymond James Initiated $15 +43.7% $10.44
2021-06-02 Goldman Sachs Matthew Sykes Initiated $55 +37.1% $40.11
2021-05-24 Guggenheim Sandy Draper Initiated $54 +37.9% $39.17

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NEO receives an overall rating of C. Strongest factors: P/B (5/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

19 Grade D
Profitability
13
Balance Sheet
2
Earnings Quality
45
Growth
41
Value
42
Momentum
42
Safety
15
Cash Flow
22
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NEO scores highest in Earnings Quality (45/100) and lowest in Balance Sheet (2/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.33
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.83
Unlikely Manipulator
Ohlson O-Score
-7.40
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB-
Score: 35.4/100
Trend: Improving
Earnings Quality
OCF/NI: -0.23x
Accruals: -8.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NEO scores 0.33, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NEO scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NEO's score of -2.83 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NEO's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NEO receives an estimated rating of BB- (score: 35.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.40x
PEG
0.08x
P/S
0.32x
P/B
0.29x
P/FCF
-37.67x
P/OCF
8.55x
EV/EBITDA
-15.34x
EV/Revenue
0.68x
EV/EBIT
-5.07x
EV/FCF
-99.12x
Earnings Yield
-51.76%
FCF Yield
-2.65%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NEO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.971
NI / EBT
×
Interest Burden
1.028
EBT / EBIT
×
EBIT Margin
-0.133
EBIT / Rev
×
Asset Turnover
0.498
Rev / Assets
×
Equity Multiplier
1.724
Assets / Equity
=
ROE
-11.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NEO's ROE of -11.4% is driven by Asset Turnover (0.498), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.97 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$9.23
Median 1Y
$6.75
5th Pctile
$2.12
95th Pctile
$21.49
Ann. Volatility
65.1%
Analyst Target
$19.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Tony Zook
Director and Chief Executive Officer
$601,539 $3,999,997 $9,127,092
Warren Stone Commercial
ercial Officer
$630,069 $2,249,994 $5,068,830
Jeffrey Sherman Financial
ancial Officer
$603,731 $2,250,000 $4,681,428
Christopher Smith
Former Director and Former Chief Executive Officer
$310,962 $3,350,004 $4,045,937
M elody Harris
Former Chief Operations Officer and Former President, Oncology Data Solutions
$269,231 $1,666,652 $3,692,445
Alicia Olivo President,
Vice President, General Counsel and Business Development
$522,500 $1,499,997 $3,049,999
Gary Passman Culture
ulture Officer
$447,962 $1,124,995 $2,443,195

CEO Pay Ratio

62:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,127,092
Avg Employee Cost (SGA/emp): $146,138
Employees: 2,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,500
+13.6% YoY
Revenue / Employee
$290,933
Rev: $727,332,000
Profit / Employee
$-43,210
NI: $-108,025,000
SGA / Employee
$146,138
Avg labor cost proxy
R&D / Employee
$14,831
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 11.9% 8.1% -0.9% -4.0% -16.3% -18.1% -13.7% -11.9% -10.9% -9.1% -9.1% -8.7% -8.1% -8.0% -8.5% -8.4% -11.3% -12.3% -12.4% -11.4% -11.41%
ROA 8.4% 5.8% -0.6% -2.5% -10.3% -11.4% -8.0% -7.0% -6.4% -5.3% -5.1% -4.9% -4.6% -4.5% -4.7% -4.7% -6.3% -6.8% -7.2% -6.6% -6.62%
ROIC -5.1% -15.5% -7.8% -10.2% -11.3% -11.3% -10.6% -9.5% -8.8% -7.8% -7.5% -7.2% -6.6% -6.4% -6.5% -6.3% -8.1% -8.5% -7.8% -7.2% -7.15%
ROCE -3.0% -5.9% -6.0% -7.5% -8.3% -9.3% -9.1% -8.2% -7.4% -6.2% -5.7% -5.3% -4.8% -4.6% -5.5% -5.4% -7.5% -8.2% -8.4% -7.8% -7.82%
Gross Margin 43.5% 38.9% 36.0% 32.6% 35.1% 38.0% 41.0% 39.9% 40.8% 41.0% 43.5% 41.9% 44.1% 44.6% 44.9% 43.6% 42.6% 42.8% 39.8% 43.3% 43.32%
Operating Margin -18.4% -32.7% -33.1% -44.4% -31.7% -30.7% -19.0% -25.6% -20.3% -15.9% -11.9% -19.6% -13.3% -12.6% -10.7% -16.6% -26.3% -14.4% -5.9% -9.8% -9.77%
Net Margin 62.3% -16.8% -33.2% -42.2% -28.2% -28.6% -16.4% -22.4% -16.6% -12.2% -9.2% -17.3% -11.3% -10.5% -8.9% -15.4% -24.9% -14.4% -5.2% -9.2% -9.16%
EBITDA Margin -9.6% -2.3% -20.4% -25.0% -16.4% -17.1% -6.0% -10.3% -4.5% -1.1% 3.1% -4.9% 0.5% 1.1% 2.1% -3.8% -15.2% -5.3% 2.8% -0.3% -0.30%
FCF Margin -10.1% -13.3% -18.8% -23.6% -24.3% -24.2% -19.0% -15.5% -11.6% -8.6% -5.2% -6.5% -4.7% -3.3% -5.2% -4.8% -2.8% -2.4% -3.0% -0.7% -0.68%
OCF Margin 1.5% -0.2% -5.5% -11.9% -15.0% -16.5% -12.9% -9.4% -6.2% -4.1% -0.3% -2.5% 0.0% 2.3% 1.1% 1.1% 2.0% 1.9% 0.7% 3.0% 3.01%
ROE 3Y Avg snapshot only -9.80%
ROE 5Y Avg snapshot only -9.04%
ROA 3Y Avg snapshot only -5.68%
ROIC 3Y Avg snapshot only -6.12%
ROIC Economic snapshot only -6.35%
Cash ROA snapshot only 1.65%
Cash ROIC snapshot only 1.95%
CROIC snapshot only -0.44%
NOPAT Margin snapshot only -11.02%
Pretax Margin snapshot only -13.70%
R&D / Revenue snapshot only 4.88%
SGA / Revenue snapshot only 48.80%
SBC / Revenue snapshot only 4.31%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 16.53 24.22 -100.61 -8.43 -1.38 -1.31 -1.60 -3.47 -3.51 -3.21 -4.63 -4.71 -4.46 -4.82 -5.30 -3.12 -1.80 -1.74 -2.80 -1.93 -2.403
P/S Ratio 2.43 2.44 1.73 0.62 0.41 0.43 0.45 0.82 0.73 0.54 0.69 0.65 0.56 0.58 0.63 0.36 0.27 0.28 0.42 0.26 0.322
P/B Ratio 1.71 1.70 0.76 0.27 0.18 0.19 0.23 0.44 0.40 0.31 0.43 0.42 0.37 0.40 0.46 0.27 0.21 0.22 0.36 0.23 0.288
P/FCF -24.09 -18.30 -9.24 -2.62 -1.70 -1.78 -2.38 -5.29 -6.30 -6.23 -13.27 -10.02 -11.79 -17.41 -12.26 -7.47 -9.76 -11.58 -13.89 -37.67 -37.673
P/OCF 161.72 1328.21 24.96 59.44 31.76 13.31 14.43 57.85 8.55 8.550
EV/EBITDA 89.13 -273.17 -19.10 -5.74 -3.83 -3.20 -5.04 -9.36 -11.27 -15.71 -34.30 -52.92 -142.11 -1300.65 -420.88 -4948.92 -14.25 -10.35 -15.93 -15.34 -15.337
EV/Revenue 2.27 2.28 1.94 0.82 0.61 0.63 0.79 1.15 1.04 0.84 1.02 0.97 0.87 0.89 0.96 0.68 0.59 0.59 0.85 0.68 0.676
EV/EBIT -39.72 -20.29 -8.78 -2.99 -2.02 -1.88 -2.70 -4.49 -4.69 -4.68 -6.70 -7.04 -7.13 -7.80 -8.59 -6.38 -4.07 -3.79 -5.78 -5.07 -5.074
EV/FCF -22.51 -17.09 -10.32 -3.47 -2.52 -2.59 -4.16 -7.40 -9.00 -9.71 -19.67 -14.98 -18.40 -26.54 -18.68 -14.22 -21.15 -24.40 -28.25 -99.12 -99.124
Earnings Yield 6.1% 4.1% -1.0% -11.9% -72.6% -76.2% -62.6% -28.9% -28.5% -31.2% -21.6% -21.2% -22.4% -20.8% -18.9% -32.1% -55.6% -57.5% -35.7% -51.8% -51.76%
FCF Yield -4.2% -5.5% -10.8% -38.1% -58.9% -56.2% -42.0% -18.9% -15.9% -16.1% -7.5% -10.0% -8.5% -5.7% -8.2% -13.4% -10.2% -8.6% -7.2% -2.7% -2.65%
PEG Ratio snapshot only 0.079
Price/Tangible Book snapshot only 7.461
EV/OCF snapshot only 22.495
EV/Gross Profit snapshot only 1.605
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.13 6.13 7.81 7.81 7.81 7.81 6.73 6.73 6.73 6.73 6.20 6.20 6.20 6.20 1.98 1.98 1.98 1.98 4.26 4.26 4.261
Quick Ratio 5.73 5.73 7.54 7.54 7.54 7.54 6.46 6.46 6.46 6.46 5.95 5.95 5.95 5.95 1.89 1.89 1.89 1.89 3.94 3.94 3.938
Debt/Equity 0.31 0.31 0.55 0.55 0.55 0.55 0.61 0.61 0.61 0.61 0.65 0.65 0.65 0.65 0.67 0.67 0.67 0.67 0.56 0.56 0.565
Net Debt/Equity -0.11 -0.11 0.09 0.09 0.09 0.09 0.17 0.17 0.17 0.17 0.21 0.21 0.21 0.21 0.24 0.24 0.24 0.24 0.37 0.37 0.374
Debt/Assets 0.22 0.22 0.33 0.33 0.33 0.33 0.35 0.35 0.35 0.35 0.36 0.36 0.36 0.36 0.37 0.37 0.37 0.37 0.35 0.35 0.347
Debt/EBITDA 17.56 -53.98 -12.49 -8.84 -7.84 -6.29 -7.63 -9.40 -11.96 -19.91 -34.74 -54.59 -158.88 -1393.35 -400.62 -6508.97 -21.26 -15.06 -12.23 -14.36 -14.362
Net Debt/EBITDA -6.28 19.30 -1.99 -1.40 -1.25 -1.00 -2.16 -2.66 -3.38 -5.64 -11.16 -17.54 -51.03 -447.55 -144.60 -2349.35 -7.67 -5.44 -8.09 -9.51 -9.508
Interest Coverage -4.14 -9.78 -21.00 -25.52 -28.30 -40.66 -63.19 -47.96 -33.34 -19.70 -13.06 -12.32 -11.42 -10.96 -11.19 -11.01 -17.13 -22.98 -28.36 -36.37 -36.368
Equity Multiplier 1.42 1.42 1.69 1.69 1.69 1.69 1.74 1.74 1.74 1.74 1.79 1.79 1.79 1.79 1.82 1.82 1.82 1.82 1.63 1.63 1.625
Cash Ratio snapshot only 1.808
Debt Service Coverage snapshot only -12.032
Cash to Debt snapshot only 0.338
FCF to Debt snapshot only -0.011
Defensive Interval snapshot only 278.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.58 0.57 0.34 0.34 0.34 0.35 0.28 0.29 0.31 0.32 0.35 0.36 0.37 0.38 0.40 0.41 0.42 0.43 0.49 0.50 0.498
Inventory Turnover 12.87 12.99 11.23 11.42 11.89 12.11 13.50 13.65 13.89 14.30 14.33 14.68 14.88 15.02 14.56 14.71 15.19 15.75 15.21 15.61 15.609
Receivables Turnover 4.84 4.80 4.42 4.44 4.47 4.54 4.40 4.57 4.76 4.96 4.71 4.87 5.01 5.13 4.69 4.77 4.89 5.03 4.70 4.82 4.816
Payables Turnover 12.69 12.81 13.86 14.10 14.67 14.94 16.75 16.93 17.24 17.74 16.99 17.40 17.65 17.81 17.67 17.86 18.43 19.12 18.82 19.32 19.316
DSO 75 76 83 82 82 80 83 80 77 74 77 75 73 71 78 76 75 73 78 76 75.8 days
DIO 28 28 32 32 31 30 27 27 26 26 25 25 25 24 25 25 24 23 24 23 23.4 days
DPO 29 28 26 26 25 24 22 22 21 21 21 21 21 20 21 20 20 19 19 19 18.9 days
Cash Conversion Cycle 75 76 89 88 87 86 88 85 82 79 81 79 77 75 82 81 79 77 82 80 80.3 days
Fixed Asset Turnover snapshot only 4.569
Operating Cycle snapshot only 99.2 days
Cash Velocity snapshot only 4.673
Capital Intensity snapshot only 1.823
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 20.8% 13.9% 9.0% 7.1% 0.1% 2.5% 5.2% 9.0% 12.7% 15.7% 16.1% 15.3% 13.9% 12.1% 11.6% 10.1% 9.7% 10.1% 10.1% 10.9% 10.95%
Net Income 14.4% 10.9% -3.0% -2.3% -3.0% -4.3% -16.3% -2.5% 21.9% 41.0% 39.0% 33.0% 31.5% 19.3% 10.5% 7.9% -32.5% -46.0% -37.2% -27.9% -27.87%
EPS 12.0% 9.9% -2.9% -2.1% -3.2% -4.3% -16.1% -2.5% 22.7% 41.6% 39.6% 33.5% 32.1% 20.1% 11.0% 8.8% -30.9% -44.9% -35.1% -26.1% -26.09%
FCF -7.0% -1.6% -2.3% -2.9% -1.4% -86.4% -6.6% 28.2% 46.2% 58.8% 68.3% 51.9% 53.5% 56.7% -10.9% 18.2% 35.5% 20.7% 36.0% 84.3% 84.28%
EBITDA -26.7% -1.2% -2.7% -5.3% -7.3% -23.1% -63.2% 6.3% 34.6% 68.5% 78.0% 82.8% 92.5% 98.6% 91.4% 99.2% -6.4% -90.6% -24.6% -352.6% -352.59%
Op. Income -49.6% -3.2% -7.5% -5.5% -5.3% -1.4% -32.7% 9.6% 24.4% 33.1% 31.6% 26.6% 27.2% 20.1% 14.5% 13.4% -20.8% -31.0% -23.3% -16.4% -16.40%
OCF Growth snapshot only 1.95%
Asset Growth snapshot only -16.98%
Equity Growth snapshot only -7.29%
Debt Growth snapshot only -21.98%
Shares Change snapshot only 1.41%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 23.1% 21.8% 20.5% 16.3% 12.6% 9.5% 7.6% 8.1% 10.9% 10.6% 10.0% 10.4% 8.7% 10.0% 10.9% 11.4% 12.1% 12.6% 12.6% 12.1% 12.08%
Revenue 5Y 22.8% 18.1% 14.7% 14.6% 14.8% 15.0% 14.9% 15.6% 16.1% 16.5% 16.4% 14.6% 12.9% 11.2% 10.1% 9.9% 11.2% 10.8% 10.4% 10.4% 10.44%
EPS 3Y 2.7% 71.0%
EPS 5Y
Net Income 3Y 3.2% 89.0%
Net Income 5Y
EBITDA 3Y -22.7%
EBITDA 5Y -7.5%
Gross Profit 3Y 19.8% 17.4% 13.7% 8.3% 2.3% -1.0% -1.1% 1.4% 8.0% 9.4% 9.6% 12.1% 9.1% 12.1% 15.8% 17.5% 20.1% 20.5% 17.7% 15.4% 15.40%
Gross Profit 5Y 21.1% 15.9% 11.1% 10.7% 9.1% 9.0% 9.3% 11.2% 13.0% 13.7% 14.0% 12.0% 10.5% 9.1% 8.3% 8.7% 11.6% 11.6% 10.5% 11.7% 11.66%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y -40.1% -67.0%
OCF 5Y -15.1% -59.8% -15.8% -21.4% -5.9% -3.7% 29.1% 16.2% 16.16%
Assets 3Y 42.3% 42.3% 54.7% 54.7% 54.7% 54.7% 34.9% 34.9% 34.9% 34.9% 19.4% 19.4% 19.4% 19.4% -4.3% -4.3% -4.3% -4.3% -7.9% -7.9% -7.89%
Assets 5Y 21.8% 21.8% 40.9% 40.9% 40.9% 40.9% 38.3% 38.3% 38.3% 38.3% 27.2% 27.2% 27.2% 27.2% 18.2% 18.2% 18.2% 18.2% 6.6% 6.6% 6.59%
Equity 3Y 50.0% 50.0% 51.2% 51.2% 51.2% 51.2% 25.3% 25.3% 25.3% 25.3% 10.7% 10.7% 10.7% 10.7% -6.6% -6.6% -6.6% -6.6% -5.7% -5.7% -5.71%
Book Value 3Y 32.4% 35.8% 39.6% 38.4% 41.8% 44.2% 19.4% 18.0% 19.2% 20.0% 7.1% 7.7% 12.1% 9.4% -7.5% -7.5% -7.6% -7.5% -6.7% -6.7% -6.73%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.98 0.96 0.91 0.95 0.97 0.97 0.95 0.95 0.95 0.96 0.96 0.98 0.96 0.97 0.95 0.96 0.98 0.98 0.97 0.98 0.979
Earnings Stability 0.42 0.43 0.00 0.43 0.14 0.22 0.46 0.65 0.38 0.42 0.60 0.73 0.38 0.37 0.53 0.60 0.36 0.35 0.44 0.45 0.446
Margin Stability 0.95 0.94 0.92 0.90 0.89 0.89 0.89 0.89 0.91 0.91 0.91 0.91 0.90 0.89 0.90 0.91 0.92 0.92 0.94 0.95 0.947
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.84 0.87 0.87 0.92 0.96 0.97 0.87 0.82 0.85 0.89 0.889
Earnings Smoothness
ROE Trend 0.11 0.07 -0.02 -0.03 -0.18 -0.18 -0.14 -0.10 -0.10 -0.06 -0.02 -0.01 0.04 0.04 0.03 0.02 -0.02 -0.04 -0.04 -0.03 -0.031
Gross Margin Trend -0.03 -0.04 -0.06 -0.06 -0.07 -0.06 -0.03 -0.00 0.01 0.02 0.04 0.04 0.05 0.05 0.05 0.04 0.03 0.01 -0.00 -0.01 -0.009
FCF Margin Trend -0.11 -0.13 -0.16 -0.19 -0.19 -0.15 -0.07 -0.00 0.06 0.10 0.14 0.13 0.13 0.13 0.07 0.06 0.05 0.04 0.02 0.05 0.050
Sustainable Growth Rate 11.9% 8.1%
Internal Growth Rate 9.2% 6.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.10 -0.02 3.20 1.63 0.50 0.50 0.46 0.40 0.30 0.24 0.02 0.18 -0.00 -0.19 -0.09 -0.10 -0.14 -0.12 -0.05 -0.23 -0.226
FCF/OCF -6.71 67.17 3.40 1.98 1.62 1.47 1.47 1.66 1.87 2.12 15.72 2.61 -112.61 -1.43 -4.85 -4.25 -1.36 -1.25 -4.16 -0.23 -0.227
FCF/Net Income snapshot only 0.051
CapEx/Revenue 11.6% 13.1% 13.2% 11.6% 9.3% 7.7% 6.1% 6.2% 5.4% 4.6% 4.9% 4.0% 4.8% 5.7% 6.2% 5.9% 4.8% 4.3% 3.7% 3.7% 3.69%
CapEx/Depreciation snapshot only 0.414
Accruals Ratio 0.08 0.06 0.01 0.02 -0.05 -0.06 -0.04 -0.04 -0.04 -0.04 -0.05 -0.04 -0.05 -0.05 -0.05 -0.05 -0.07 -0.08 -0.08 -0.08 -0.081
Sloan Accruals snapshot only -0.049
Cash Flow Adequacy snapshot only 0.815
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0%
FCF Payout Ratio
Total Payout Ratio 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -37.2% -36.3% -50.4% -69.5% -2.2% -6.4% -5.5% -1.7% -1.6% -1.7% -1.1% -1.0% -1.7% -1.4% -1.1% -2.0% -0.9% -0.6% -0.3% -0.2% -0.17%
Total Shareholder Return -37.2% -36.3% -50.4% -69.5% -2.2% -6.4% -5.5% -1.7% -1.6% -1.7% -1.1% -1.0% -1.7% -1.4% -1.1% -2.0% -0.9% -0.6% -0.3% -0.2% -0.17%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.16 1.33 0.55 0.76 0.91 0.92 0.91 0.90 0.91 0.90 0.91 0.93 0.94 0.97 0.98 0.99 0.99 1.00 0.98 0.97 0.971
Interest Burden (EBT/EBIT) -2.23 -0.67 0.14 0.35 1.09 1.07 1.07 1.03 1.02 1.04 1.08 1.08 1.09 1.09 1.09 1.09 1.06 1.04 1.04 1.03 1.028
EBIT Margin -0.06 -0.11 -0.22 -0.27 -0.30 -0.33 -0.29 -0.26 -0.22 -0.18 -0.15 -0.14 -0.12 -0.11 -0.11 -0.11 -0.14 -0.15 -0.15 -0.13 -0.133
Asset Turnover 0.58 0.57 0.34 0.34 0.34 0.35 0.28 0.29 0.31 0.32 0.35 0.36 0.37 0.38 0.40 0.41 0.42 0.43 0.49 0.50 0.498
Equity Multiplier 1.41 1.41 1.59 1.59 1.59 1.59 1.71 1.71 1.71 1.71 1.76 1.76 1.76 1.76 1.80 1.80 1.80 1.80 1.72 1.72 1.724
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $2.73 $1.99 $-0.34 $-1.44 $-5.92 $-6.56 $-5.78 $-5.02 $-4.57 $-3.83 $-3.49 $-3.34 $-3.11 $-3.06 $-3.11 $-3.05 $-4.07 $-4.44 $-4.20 $-3.84 $-3.84
Book Value/Share $26.45 $28.32 $45.02 $44.82 $44.66 $44.54 $40.01 $39.91 $39.81 $39.70 $37.38 $37.33 $37.24 $37.08 $35.62 $35.42 $35.26 $35.27 $32.51 $32.38 $32.08
Tangible Book/Share $13.81 $14.79 $5.64 $5.62 $5.60 $5.58 $2.69 $2.68 $2.67 $2.67 $1.81 $1.81 $1.81 $1.80 $1.57 $1.57 $1.56 $1.56 $1.00 $0.99 $0.99
Revenue/Share $18.62 $19.77 $19.68 $19.65 $19.72 $19.96 $20.44 $21.19 $22.00 $22.87 $23.49 $24.21 $24.85 $25.37 $26.08 $26.39 $26.93 $27.72 $28.27 $28.88 $28.88
FCF/Share $-1.87 $-2.64 $-3.69 $-4.63 $-4.80 $-4.84 $-3.88 $-3.29 $-2.55 $-1.98 $-1.22 $-1.57 $-1.18 $-0.85 $-1.34 $-1.27 $-0.75 $-0.67 $-0.85 $-0.20 $-0.20
OCF/Share $0.28 $-0.04 $-1.09 $-2.34 $-2.97 $-3.30 $-2.65 $-1.99 $-1.36 $-0.93 $-0.08 $-0.60 $0.01 $0.59 $0.28 $0.30 $0.55 $0.53 $0.20 $0.87 $0.87
Cash/Share $11.29 $12.09 $20.94 $20.84 $20.77 $20.71 $17.56 $17.52 $17.47 $17.42 $16.49 $16.46 $16.42 $16.35 $15.27 $15.19 $15.12 $15.12 $6.20 $6.18 $5.66
EBITDA/Share $0.47 $-0.16 $-1.99 $-2.80 $-3.15 $-3.91 $-3.21 $-2.60 $-2.04 $-1.22 $-0.70 $-0.44 $-0.15 $-0.02 $-0.06 $-0.00 $-1.11 $-1.57 $-1.50 $-1.27 $-1.27
Debt/Share $8.31 $8.90 $24.89 $24.78 $24.70 $24.62 $24.49 $24.43 $24.37 $24.30 $24.29 $24.25 $24.20 $24.09 $23.90 $23.76 $23.66 $23.66 $18.36 $18.28 $18.28
Net Debt/Share $-2.97 $-3.18 $3.96 $3.94 $3.93 $3.91 $6.93 $6.92 $6.90 $6.88 $7.80 $7.79 $7.77 $7.74 $8.63 $8.58 $8.54 $8.54 $12.15 $12.10 $12.10
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.335
Altman Z-Prime snapshot only 0.243
Piotroski F-Score 7 4 2 2 4 3 3 3 4 4 4 4 5 5 5 5 3 3 4 4 4
Beneish M-Score -2.13 -2.17 -2.06 -2.10 -2.20 -2.33 -2.68 -2.70 -2.70 -2.62 -2.67 -2.62 -2.66 -2.71 -2.63 -2.63 -2.69 -2.69 -2.74 -2.83 -2.832
Ohlson O-Score snapshot only -7.401
ROIC (Greenblatt) snapshot only -22.03%
Net-Net WC snapshot only $-5.69
EVA snapshot only $-197101160.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 44.87 53.46 32.58 33.59 34.29 34.58 35.43 35.04 35.06 35.31 35.43 35.25 36.08 35.72 32.02 31.46 32.37 31.53 35.72 35.37 35.375
Credit Grade snapshot only 13
Credit Trend snapshot only 3.911
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 25

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms